Site-specific integration by the adeno-associated virus rep protein

Area of Science:

• Genetics
• Molecular Biology
• Gene Therapy

Background:

• Gene transfer technology has long aimed for precise insertion into the human genome.
• Advances in mammalian genetics have enabled genome editing and homologous recombination in human somatic cells for clinical use.
• Site-specific integration, using enzymes for targeted gene insertion, is a promising next-generation gene transfer technology.

Purpose of the Study:

• To review the use of adeno-associated virus (AAV) Rep protein for gene insertion.
• To evaluate the AAVS1 locus on human chromosome 19 as a target for site-specific gene integration.
• To discuss the potential of AAV Rep-mediated integration for somatic transgenesis.

Main Methods:

• Focus on the Rep protein (replicase/integrase) from adeno-associated virus (AAV).
• Utilizing the natural AAV integration site (AAVS1) on human chromosome 19.
• Reviewing advancements in site-specific integration technologies.

Main Results:

• The Rep protein of AAV facilitates gene insertion.
• The AAVS1 locus on chromosome 19 is a suitable target for gene integration.
• Site-specific integration is progressing towards clinical compatibility.

Conclusions:

• Rep-mediated site-specific integration offers a powerful tool for gene transfer.
• The AAVS1 locus provides an ideal target for somatic cell gene therapy.
• This technology represents a significant advancement in gene therapy applications.